Neurogene Inc (NGNE) Stock Analysis

Neurogene Inc (NGNE) is a publicly traded company in the HEALTHCARE sector. It trades at $26.14, carries a market capitalization of $435.18M. This page summarizes the public market data, fundamentals, and frequently asked questions for NGNE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $26.14
• Market Cap: $435.18M
• EPS: $-4.55
• 52-Week High: $37.27
• 52-Week Low: $14.65

Market Sentiment

Neurogene Inc currently has a Neutral sentiment score of -0.07.

About Neurogene Inc

None

GNG Research Analysis

GNG Research scores Neurogene Inc (NGNE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NGNE.

Frequently Asked Questions

Does NGNE pay dividends?

Neurogene Inc (NGNE) does not currently pay a regular dividend.

What is NGNE's market cap?

Neurogene Inc (NGNE) has a market capitalization of $435.18M with a current stock price of $26.14.